Technological watch
Collaboration to improve UK bioscience
A group of companies in the North of England has been formed to help accelerate the bioscience sector in the Tees Valley.
Plans are for the Northern Bio-Accelerator Partnership (NBioP) to create a bioprocessing, biomanufacturing and biopharmaceutical hub in based at Darlington’s Central Park.
‘With a high-density cluster of expertise and a well-developed business ecosystem, the North East offers a bioscience community that is second to none in the UK,’ a press release said. ‘Access to a mature supply chain and highly-skilled workforce, with much lower business costs than other areas of the UK, means a start-up company can establish itself in the region for life.’
This story uses material from Tees University, with editorial changes made by Materials Today. The views expressed in this article do not necessarily represent those of Elsevier.
Plans are for the Northern Bio-Accelerator Partnership (NBioP) to create a bioprocessing, biomanufacturing and biopharmaceutical hub in based at Darlington’s Central Park.
‘With a high-density cluster of expertise and a well-developed business ecosystem, the North East offers a bioscience community that is second to none in the UK,’ a press release said. ‘Access to a mature supply chain and highly-skilled workforce, with much lower business costs than other areas of the UK, means a start-up company can establish itself in the region for life.’
This story uses material from Tees University, with editorial changes made by Materials Today. The views expressed in this article do not necessarily represent those of Elsevier.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 870292.
